Aster Capital Management (Difc) LTD Evolus, Inc. Call Options Transaction History

Aster Capital Management (Difc) LTD

  • $198 Billion
  • Q3 2025

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $405M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Aster Capital Management (Difc) LTD Portfolio

Follow Aster Capital Management (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aster Capital Management (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aster Capital Management (Difc) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email